Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2026 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungenAcceptable Use
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to Reports
Fundraising

Future Meat Technologies

Future Meat Technologies Raises $347M in Series B

Rehovot, IsraelDecember 29, 20212 min read
Employees
100+

Future Meat Technologies Raises $347M in Series B


Future Meat Technologies has successfully raised $347M in a Series B at a $900M valuation led by S2G Ventures, ADM Ventures.


Company Overview


Future Meat Technologies is a FoodTech company headquartered in Rehovot, Israel, founded in 2018 with 100+ employees.


Cultivated meat production


Fundraising Details


  • Amount Raised: $347M
  • Round Type: Series B
  • Valuation: $900M
  • Date: 2021-12-29
  • Investors: S2G Ventures, ADM Ventures

About Future Meat Technologies


Cultivated meat production The company is positioned in the FoodTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Rehovot, Israel
  • Founded: 2018
  • Team Size: 100+
  • Industry: FoodTech

What This Means


This funding round demonstrates strong investor confidence in Future Meat Technologies's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The FoodTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Future Meat Technologies's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $900M valuation marks an important milestone for Future Meat Technologies, positioning the company among notable players in the FoodTech industry.


Looking Ahead


With this new capital, Future Meat Technologies is well-positioned to execute on its growth strategy and continue building innovative solutions in the FoodTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2021-12-29. For more information about Future Meat Technologies, visit their headquarters at Rehovot, Israel.

Company Info

Headquarters
Rehovot, Israel
Founded
2018
Team Size
100+

Topics

Fundraising(2912)Series B(306)FoodTechFuture Meat Technologies

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free